SHOCKWAVE MED INC's ticker is SWAV and the CUSIP is 82489T104. A total of 168 filers reported holding SHOCKWAVE MED INC in Q3 2020. The put-call ratio across all filers is 0.36 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $25,881,179 | -19.5% | 129,986 | +15.4% | 0.05% | -16.1% |
| Q2 2023 | $32,150,356 | +29.6% | 112,643 | -1.6% | 0.06% | +21.7% |
| Q1 2023 | $24,809,585 | +252.2% | 114,419 | +234.0% | 0.05% | +187.5% |
| Q4 2022 | $7,043,738 | -79.8% | 34,257 | -72.6% | 0.02% | -79.5% |
| Q3 2022 | $34,814,000 | +30.5% | 125,200 | -10.3% | 0.08% | +34.5% |
| Q2 2022 | $26,686,000 | +585.7% | 139,594 | +643.1% | 0.06% | +625.0% |
| Q1 2022 | $3,892,000 | +5.0% | 18,785 | -9.6% | 0.01% | +14.3% |
| Q4 2021 | $3,705,000 | -19.6% | 20,789 | -7.1% | 0.01% | -30.0% |
| Q3 2021 | $4,607,000 | -2.3% | 22,370 | -10.0% | 0.01% | 0.0% |
| Q2 2021 | $4,717,000 | +62.2% | 24,861 | +3.3% | 0.01% | +42.9% |
| Q1 2021 | $2,908,000 | +27.9% | 24,059 | +9.8% | 0.01% | +16.7% |
| Q4 2020 | $2,273,000 | +78.0% | 21,908 | +30.0% | 0.01% | +50.0% |
| Q3 2020 | $1,277,000 | +224.1% | 16,847 | +143.9% | 0.00% | +300.0% |
| Q2 2019 | $394,000 | – | 6,906 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prossimo Advisors, LLC | 18,758 | $3,735 | 8.81% |
| Matisse Capital | 22,175 | $4,415,043 | 3.12% |
| Atika Capital Management LLC | 116,500 | $23,195,150 | 3.04% |
| APEIRON CAPITAL Ltd | 18,300 | $3,643,530 | 2.44% |
| AtonRa Partners | 4,374 | $870,863 | 1.83% |
| Rhenman & Partners Asset Management AB | 81,000 | $16,127,100 | 1.74% |
| GILDER GAGNON HOWE & CO LLC | 549,173 | $109,340,363 | 1.66% |
| Eversept Partners, LP | 84,462 | $16,816,384 | 1.42% |
| Biondo Investment Advisors, LLC | 37,451 | $7,456,394 | 1.40% |
| DEEPWATER ASSET MANAGEMENT, LLC | 15,321 | $3,050,411 | 1.40% |